Health Care: Drugs

Regulus Therapeutics Inc (RGLS: NASDAQ)

$1.6 -0.05 | -3.03%
03/30/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 1.19M 20.76M 7.67M 19.57M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 1.19M 20.76M 7.67M 19.57M
Selling, General, and Administrative Expenses 18.39M 19.13M 11.53M 7.43M
Research & Development 64.31M 56.39M 41.05M 29.94M
Operating Income before D & A (EBITDA) -81.50M -54.76M -44.91M -17.80M
Depreciation & Amortization 2.94M 3.06M 3.09M 2.80M
Interest Income 844.00K 855.00K 388.00K 292.00K
Other Income - Net 0.00 -1.81M -12.12M -1.15M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -83.60M -58.78M -59.73M -21.45M
Interest Expense 1.18M 52.00K 39.00K 36.00K
Pre-Tax Income -84.78M -58.83M -59.77M -21.49M
Income Taxes -4.00K -18.00K 1.00K -23.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -81.84M -55.75M -56.68M -18.67M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -81.84M -55.75M -56.68M -18.67M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -81.84M -55.75M -56.68M -18.67M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-81.84M -55.75M -56.68M -18.67M
Preferred Dividends
Net Income Available To Common -81.84M -55.75M -56.68M -18.67M
Basic EPS from Continuing Ops. -1.55 -1.08 -1.29 -0.49
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.55 -1.08 -1.29 -0.49
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.55 -1.08 -1.29 -0.49
Basic Normalized Net Income/Share -1.55 -1.08 -1.29 -0.49
EPS fr Continuing Ops. -1.55 -1.08 -1.29 -0.49
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.55 -1.08 -1.29 -0.49
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.55 -1.08 -1.29 -0.49
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.55 -1.08 -1.29 -0.49
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with RGLS

Latest RGLS Headlines from TheStreet

More Financial News for RGLS

Press Releases for RGLS

See All Press Releases

Partner Headlines for RGLS

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter